FILING ANALYSIS · MONDAY, NOVEMBER 9
KALA BIO, Inc. KALA — 8-K: Results of Operations and Financial Condition
neutral
KALA BIO reports a 90% year-over-year reduction in quarterly net loss to $0.8 million and has $7.0 million in cash with no debt, but this is preliminary and unaudited, subject to completion of financial close procedures and review by its independent auditor.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →